We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Plans Independent Audit of Drug Application Transparency Initiative
FDA Plans Independent Audit of Drug Application Transparency Initiative
May 22, 2013
As part of fulfilling a key user fee commitment, the FDA is asking the White House to approve plans to survey companies that submit applications to the agency to assess the effectiveness of a new drug approvals transparency initiative.